Nirmidas Biotech - Crunchbase Company Profile & Funding

Q: Who invested in Nirmidas Biotech?

Nirmidas Biotech is funded by StartX (Stanford-StartX Fund).

Q: When was the last funding round for Nirmidas Biotech?

Nirmidas Biotech closed its last funding round on obfuscated from a Series A round.

Q: How much funding has Nirmidas Biotech raised to date?

Nirmidas Biotech has raised obfuscated.

Overview

Nirmidas Biotech

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Nirmidas Biotech

CB Rank

254973

Nirmidas provides innovative solutions

Founded

obfuscation

Private

Series A

San Francisco, California, United States

1-10

nirmidas.com

Biotechnology

Health Care

Health Diagnostics

Manufacturing

Funding Rounds

Series A

OBF

obfuscation

Seed

OBF

obfuscation

Key People

Meijie Tang: Co-founder, CEO
Hongjie Dai: Co-Founder

Details

Legal Name

Nirmidas Biotech, Inc.

Operating Status

Active

Company Type

For Profit

Founders

Hongjie Dai, Meijie Tang

About the Company

Nirmidas provides innovative solutions to life science and healthcare technological problems and aims to improve human life quality for the world. Nirmidas develops, manufactures, and markets breakthrough biological testing, assay and imaging technologies, based on a novel red to near infrared fluorescence enhancing detection platform. We aim to

develop personal and portable diagnostics systems for early disease diagnosis and prognosis monitoring, as well as for population-based screening. Our products lie at the intersection of life science research, in vitro diagnosis and digital healthcare.

Phone Number

408-439-9138

Contact Email

info@nirmidas.com

Diversity Spotlight

Women Founded

Women Led

Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

pGOLD™ Assay Platform and Slides

A microarray platform using plasmonic gold-coated slides to enhance near-infrared fluorescence signals for biomarker detection and bioassays.

MidaScan™ and MidaScan™-IR Confocal Scanners

Confocal scanning instruments designed to read pGOLD™ assay slides and microplates for fluorescence-based bioassays.

Research & Development

Nirmidas Biotech is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series A - Nirmidas Biotech	—	obfuscated obfuscation	—	Series A
obfuscated obfuscation	Series A - Nirmidas Biotech	—	obfuscated obfuscation	—	Series A
obfuscated obfuscation	Series A - Nirmidas Biotech	—	obfuscated obfuscation	—	Series A
obfuscated obfuscation	Series A - Nirmidas Biotech	—	obfuscated obfuscation	—	Series A
obfuscated obfuscation	Series A - Nirmidas Biotech	—	obfuscated obfuscation	—	Series A

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series A - Nirmidas Biotech	—	obfuscated obfuscation	—	Series A
obfuscated obfuscation	Series A - Nirmidas Biotech	—	obfuscated obfuscation	—	Series A
obfuscated obfuscation	Series A - Nirmidas Biotech	—	obfuscated obfuscation	—	Series A
obfuscated obfuscation	Series A - Nirmidas Biotech	—	obfuscated obfuscation	—	Series A
obfuscated obfuscation	Series A - Nirmidas Biotech	—	obfuscated obfuscation	—	Series A

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
StartX (Stanford-StartX Fund)	No	Seed Round - Nirmidas Biotech	—
StartX (Stanford-StartX Fund)	No	Seed Round - Nirmidas Biotech	—
StartX (Stanford-StartX Fund)	No	Seed Round - Nirmidas Biotech	—
StartX (Stanford-StartX Fund)	No	Seed Round - Nirmidas Biotech	—
StartX (Stanford-StartX Fund)	No	Seed Round - Nirmidas Biotech	—